Loading…
Based on limited metadata without access to the full warning letter text, this FDA warning issued to New Era Naturals, LLC on January 30, 2019 involved a product categorized as "Other," suggesting it may fall outside standard drug or device classifications. The specific nature of the regulatory violations cannot be determined from the available metadata, as no subject line or detailed violation information is provided. The issuing office is also not specified in the metadata, which limits clarity on which FDA division oversaw this enforcement action. To understand the specific compliance issues cited, the complete warning letter would need to be reviewed.